iBio, Inc. (IBIO) vs RenovoRx, Inc. (RNXT)

iBio, Inc. and RenovoRx, Inc. are both Biotechnology companies. iBio, Inc. and RenovoRx, Inc. are of similar size ($77.3M and $75.8M). iBio, Inc. has the higher net margin (0.00% vs −621.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, iBio, Inc. leads on 9 and RenovoRx, Inc. on 5.

Valuation

Metric IBIO RNXT Biotechnology median
P/E n/m n/m 7.88
P/S 183.45 39.73 11.47
P/B 1.44 8.74 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 55.05 37.37 10.73
Earnings yield (28.57%) (18.67%) (28.84%)
Free cash flow yield (19.57%) (15.20%) (23.03%)

Profitability

Metric IBIO RNXT Biotechnology median
Gross margin 100.00% 84.41% 65.16%
Operating margin 0.00% (685.22%) 0.00%
Net margin 0.00% (621.71%) 0.00%
Free cash flow margin 0.00% (604.10%) 0.00%
Return on equity (65.70%) (125.23%) (57.72%)
Return on assets (54.04%) (97.83%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IBIO RNXT Biotechnology median
Revenue growth (TTM) (66.55%) — 5.64%
EPS growth (last fiscal year) 81.71% 20.00% —
Revenue growth, 5-year CAGR (42.83%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IBIO RNXT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.85 5.74 4.73
Net debt to EBITDA 2.57 0.56 0.96

Dividend

Metric IBIO RNXT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric IBIO RNXT Biotechnology median
Market cap 77.28m 75.82m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack